Barbara Berry serves as Executive at Myriad Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Barbara Berry has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 24, 2010 involved exercising options for 526 shares valued at $2.1K.
Barbara Berry currently holds 17,284 shares of Myriad Pharmaceuticals, Inc. (MYRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Berry has been a net neutral trader of MYRX stock. They have purchased $0 and sold $0 worth of shares.
Barbara Berry's most recent insider trade was on Feb 24, 2010, when they sold 526 shares at $3.96 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |